Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome
About
Immune-mediated, non-communicable diseases, such as autoimmune diseases, allergic diseases and asthma, are chronic disorders in which the immune system plays a pivotal role. The World Health Organisation (WHO) has highlighted the seriousness of autoimmunity and its association with exposure to the environment.
EXIMIOUS aims to deliver a new way of assessing the human exposome, i.e. the exposures to environmental factors that one experiences throughout life, and shed light on its association to immune-mediated diseases.
Partners
EXIMIOUS is part of the European Human Exposome Network and brings together 15 partner organisations from 7 European countries.
FAQ
Don’t know what the exposome is?
Want to know more about exposure-related immune diseases?
Curious to know more about what to expect from this project?
Latest news
EXIMIOUS Project Showcased at CYTO 2025
Unni Nygaard from the Norwegian Institute of Public Health presented new research from the EXIMIOUS project at CYTO 2025, the leading international congress for cytometry. Her poster focused on immune profiling results from whole blood samples collected from Romanian miners, analysed using CyTOF (Cytometry by Time-of-Flight). The study aims to better understand how environmental exposures
Final European Human Exposome Newsletter published
The final issue of the EHEN newsletter is out! It features an overview of EHEN’s policy findings and an introduction to the International Human Exposome Network (IHEN), a new network that will bring the exposome community together and build on EHEN’s work in terms of tools and training opportunities. The issue also contains all the latest
Final EXIMIOUS General Assembly celebrates five and a half years of research
The EXIMIOUS consortium held its final General Assembly on 26–27 May 2025, hosted by the coordination team at KU Leuven. The hybrid meeting took place at the Faculty Club in Leuven and online, bringing together project partners, the Project Officer (PO), the Scientific Advisory Board (SAB) and select external stakeholders to review the project’s progress
Project facts
EXIMIOUS is a 5 year Research and Innovation Action funded by the European Union’s Horizon 2020 programme.
- Concept: introduce a new approach to mapping exposure-induced immune effects by combining exposomics and immunomics in a unique toolbox.
- Budget: 10.8 million Euro
- Duration: 01.01.2020 - 31.12.2024
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874707.
